Psyence Biomedical (PBM) news
Recent news
Psyence Biomedical shares resume trading, extend gain to 26%
Psyence Biomedical (PBM) shares resumed trading on August 18, 2026, extending gains to 26% following a period of limited availability. The stock closed at $3.35 per share on August 12, 2026, representing a significant increase from its 52-week low of $1.92. The company, which operates in the…
AInvest Wire · Aug 18, 2026Psyence Biomedical halted after spiking 9.7% to session high
AInvest Wire · Aug 18, 2026Psyence Biomedical to not proceed with Clairvoyant acquisition
Psyence Biomedical to not proceed with Clairvoyant acquisition The Australian-based biotech company, Psyence Biomed (ASX:PSY), has announced that it will not proceed with its previously announced acquisition of Clairvoyant Limited (ASX:CLV) [1]. The decision comes after careful consideration of…
AInvest Wire · Oct 4, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.